Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Joensuu, Heikki; Kellokumpu‐Lehtinen, Pirkko‐Liisa; Bono, Petri; Alanko, Tuomo; Kataja, Vesa; Asola, R.; Utriainen, Tapio; Kokko, R.; Hemminki, Akseli; Tarkkanen, Maija; Turpeenniemi‐Hujanen, Taina; Jyrkkiö, Sirkku; Flander, Martti; Helle, Leena; Ingalsuo, Seija; Johansson, Kaisu; Jääskeläinen, Anna-Stina; Pajunen, Marjo; Rauhala, Mervi; Kaleva‐Kerola, Jaana; Salminen, Tapio; Leinonen, Mika; Elomaa, Inkeri; Isola, Jorma

doi:10.1056/nejmoa053028

Public

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Published in New England Journal of Medicine • Feb 22, 2006

Authors:

Heikki Joensuu

Pirkko‐Liisa Kellokumpu‐Lehtinen

Petri Bono

Abstract

BACKGROUND: We compared docetaxel with vinorelbine for the adjuvant treatment of early breast cancer. Women with tumors that overexpressed HER2/neu were also assigned to receive concomitant treatment with trastuzumab or no such treatment. METHODS: We randomly assigned 1010 women with axillary-node-p...

Subject

Vinorelbine

Trastuzumab

Docetaxel

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!